Entinostat is a synthetic benzamide derivative class I histone deacetylase (HDAC) inhibitor that can inhibit cell proliferation and promote breast cancer cell apoptosis, thereby treating breast cancer (Trapani et al., 2017). Here, HDAC9 is linked to breast cancer.